Evidence map›Paper›PMID 42738086›Full record

ArticleMaterials (Basel, Switzerland)2026

Boosting Stability of Hybrid Manganese Bromide Microcrystals by Zn

Huidong Tang, Pengcheng Jiang, Xinyi Wen, Yulu He, Simeng Wu, Xin Xiong, Yanqiao Xu, Zhi Wu, Qing Hu

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huidong TangSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.ORCID 0000-0002-4900-8877
Pengcheng JiangSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.ORCID 0009-0008-0290-3891
Xinyi WenSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.
Yulu HeSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.
Simeng WuSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.
Xin XiongSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.ORCID 0009-0003-4817-3031
Yanqiao XuNational Engineering Research Center for Domestic & Building Ceramics, Jingdezhen Ceramic University, Jingdezhen 333001, China.
Zhi WuSchool of Material Science and Engineering, Hunan Institute of Technology, Hengyang 421002, China.
Qing HuSchool of Material Science and Engineering, Jingdezhen Ceramic University, Jingdezhen 333001, China.ORCID 0000-0002-6417-9543

Funding

National Natural Science Foundation of China 52362038the Characteristic Application Discipline of Material Science and Engineering in Hunan Province [2022]351, XK20260206, XK20260205the Hunan Provincial Natural Science Foundation of China 2025JJ70161, 2026JJ60488, 2026JJ90071the Hunan University Students Innovation and Entrepreneurship Training Program S202611528037the Jiangxi Provincial Natural Science Foundation 20232BAB204012the Jingdezhen Science and Technology Bureau Planning Project 2025GY004the Scientific Research Fund of Hunan Provincial Education Department 24A0665, 24A0653, 24B0834, 25B0841
6 · The paper itself

Abstract

Hybrid manganese bromides have emerged as promising lead-free narrow-band green emitters for wide-gamut displays, but their practical application is still limited by insufficient operational stability. Herein, Zn

Indexed as

narrow-band green emittersstabilitywide-gamut displaysZn2+-substituted hybrid manganese bromide

Identifiers

PMID42738086
PMCPMC13567270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.